Organozen Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 Cr
as on 04-01-2025
- Revenue %
(FY 2023)
- Profit 14.29%
(FY 2023)
- Ebitda 14.29%
(FY 2023)
- Net Worth -5.74%
(FY 2023)
- Total Assets 328.55%
(FY 2023)
About Organozen Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 Cr.
Nagesh Walimbe, Leena Walimbe, and Shatanu Savrekar serve as directors at the Company.
- CIN/LLPIN
U24100TG2020PTC141849
- Company No.
141849
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Organozen Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shatanu Savrekar  | Director | 17-Jul-2020 | Current |
| Nagesh Walimbe | Director | 17-Jul-2020 | Current |
| Leena Walimbe | Director | 17-Jul-2020 | Current |
Financial Performance of Organozen Chemicals.
Organozen Chemicals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 14.29% increase in profit. The company's net worth dipped by a decrease of 5.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Organozen Chemicals?
Unlock access to Organozen Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Zen Adsorptions Private LimitedActive 28 years 6 monthsNagesh Walimbe, Leena Walimbe and 1 more are mutual person
Zen Chemiconsultech Private LimitedActive 28 years 6 monthsNagesh Walimbe and Leena Walimbe are mutual person
- Zen Distillation Technologies Private LimitedActive 14 years 8 months
Nagesh Walimbe and Leena Walimbe are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
City Union Bank Limited Creation Date: 28 Feb 2022 | ₹5.00 Cr | Open |
How Many Employees Work at Organozen Chemicals?
Organozen Chemicals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Organozen Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Organozen Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
